{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:26:25Z","timestamp":1785878785656,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejphar.2024.176611","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T15:13:51Z","timestamp":1713885231000},"page":"176611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-\u03baB pathways"],"prefix":"10.1016","volume":"974","author":[{"given":"Liumei","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1354-4079","authenticated-orcid":false,"given":"Yinhai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-0346","authenticated-orcid":false,"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-4299","authenticated-orcid":false,"given":"Xiangling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibiao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176611_bib1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/oby.2010.352","article-title":"Efficacy and safety of cp-945,598, a selective cannabinoid Cb1 receptor antagonist, on weight loss and maintenance","volume":"19","author":"Aronne","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2024.176611_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"Nf-kappab in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2024.176611_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.dld.2021.06.005","article-title":"Treatment patterns and intensification within 5 Year of follow-up of the first-line anti-tnf\u03b1 used for the treatment of ibd: results from the verne study","volume":"54","author":"Bastida","year":"2022","journal-title":"Dig. Liver Dis. : Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Stud. Liver"},{"key":"10.1016\/j.ejphar.2024.176611_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell biology of tight junction barrier regulation and mucosal disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejphar.2024.176611_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/glia.20904","article-title":"Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro","volume":"58","author":"Cerciat","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2024.176611_bib6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1124\/dmd.108.023861","article-title":"Metabolic disposition of [14c]Bazedoxifene in healthy postmenopausal women","volume":"37","author":"Chandrasekaran","year":"2009","journal-title":"Drug metabolism and disposition: Biol. fate Chem."},{"key":"10.1016\/j.ejphar.2024.176611_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2474-11-130","article-title":"Safety of Bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis","volume":"11","author":"Christiansen","year":"2010","journal-title":"BMC Muscoskel. Disord."},{"key":"10.1016\/j.ejphar.2024.176611_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010025","article-title":"The role of succinate in the regulation of intestinal inflammation","volume":"11","author":"Connors","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.176611_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrgastro.2015.135","article-title":"Biologic agents for ibd: practical insights","volume":"12","author":"Danese","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.176611_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-010-1302-6","article-title":"Safety and tolerability of Bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled Phase 3 trial","volume":"22","author":"de Villiers","year":"2011","journal-title":"Osteoporos. Int. : A J. Established Result Cooperat. Between Eur. Found. Osteoporos. Natl Osteoporos. Found. USA"},{"key":"10.1016\/j.ejphar.2024.176611_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136966","article-title":"Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response","volume":"23","author":"Elhag","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176611_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109521","article-title":"A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state","volume":"36","author":"Fremder","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2024.176611_bib13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s40265-015-0477-8","article-title":"Cobimetinib: first global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2024.176611_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmi.2021.08.007","article-title":"Pretomanid for tuberculosis: a systematic review","volume":"28","author":"Gils","year":"2022","journal-title":"Clin. Microbiol. Infection : the Off Publ. Eur. Soc. Clin.Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejphar.2024.176611_bib15","article-title":"Protective effects of a novel probiotic Bifidobacterium pseudolongum on the intestinal barrier of colitis mice via modulating the ppar\u03b3\/stat3 pathway and intestinal microbiota","volume":"11","author":"Guo","year":"2022","journal-title":"Foods"},{"key":"10.1016\/j.ejphar.2024.176611_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043817","article-title":"Inflammatory bowel diseases and gut microbiota","volume":"24","author":"Haneishi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176611_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/gastro\/goac008","article-title":"Rewiring host-microbe interactions and barrier function during gastrointestinal inflammation","volume":"10","author":"Jensen","year":"2022","journal-title":"Gastroenterol.Rep."},{"key":"10.1016\/j.ejphar.2024.176611_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2024.176611_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41575-022-00738-z","article-title":"Improving ibd outcomes in the era of many treatment options","volume":"20","author":"Kobayashi","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.176611_bib20","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","article-title":"Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity","volume":"146","author":"Komm","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2024.176611_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmed.2023.01.001","article-title":"Ibd disease-modifying therapies: insights from emerging therapeutics","volume":"29","author":"Kotla","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176611_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2011.594808","article-title":"Dronedarone: an overview","volume":"44","author":"Kozlowski","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2024.176611_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00011-019-01217-z","article-title":"Bazedoxifene protects cerebral autoregulation after traumatic brain injury and attenuates impairments in blood-brain barrier damage: involvement of anti-inflammatory pathways by blocking mapk signaling","volume":"68","author":"Lan","year":"2019","journal-title":"Inflamm. Res. : Off. J. Eur. Histamine Res. Soc... [et al."},{"key":"10.1016\/j.ejphar.2024.176611_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.176611_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory bowel diseases (ibd) and the microbiome-searching the crime scene for clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2024.176611_bib26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/jm401144z","article-title":"Drug design targeting protein-protein interactions (ppis) using multiple ligand simultaneous docking (mlsd) and drug repositioning: discovery of raloxifene and Bazedoxifene as novel inhibitors of il-6\/gp130 interface","volume":"57","author":"Li","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176611_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of ibd: targets, mechanisms and related therapies","volume":"71\u201372","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2024.176611_bib28","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.7150\/thno.43716","article-title":"Parthenolide ameliorates colon inflammation through regulating treg\/Th17 balance in a gut microbiota-dependent manner","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2024.176611_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106146","article-title":"Emerging pharmacotherapy for inflammatory bowel diseases","volume":"178","author":"Luo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.176611_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173822","article-title":"Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of il-6\/il-6r\/stat3 signaling","volume":"893","author":"Luo","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176611_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2017.03.007","article-title":"Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease","volume":"4","author":"Martini","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.176611_bib32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","article-title":"Inflammation and malnutrition in inflammatory bowel disease","volume":"8","author":"Massironi","year":"2023","journal-title":"The lancet. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.176611_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262485","article-title":"Serms (selective estrogen receptor modulator), acting as estrogen receptor \u0392 agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-\u0391-induced migration via specific inhibition of akt signaling pathway","volume":"17","author":"Matsushima-Nishiwaki","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176611_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of Bazedoxifene on bmd and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study","volume":"23","author":"Miller","year":"2008","journal-title":"J. Bone Miner. Res. : the Off. J. Am. Soc. Bone Mineral Res."},{"key":"10.1016\/j.ejphar.2024.176611_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-021-03484-5","article-title":"A myeloid-stromal niche and Gp130 rescue in nod2-driven crohn's disease","volume":"593","author":"Nayar","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176611_bib36","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejphar.2024.176611_bib37","first-page":"573","article-title":"Gut microbiota and ibd: causation or correlation? Nature reviews","volume":"14","author":"Ni","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.176611_bib38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fmicb.2016.00925","article-title":"Bifidobacteria and their role as members of the human gut microbiota","volume":"7","author":"O'Callaghan","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2024.176611_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2013.06.008","article-title":"Assessment of the safety of long-term Bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, Phase 3 study","volume":"76","author":"Palacios","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.ejphar.2024.176611_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/nu9060555","article-title":"Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases","volume":"9","author":"Plaza-D\u00edaz","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.176611_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.176611_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40262-018-0703-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of dabrafenib","volume":"58","author":"Puszkiel","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2024.176611_bib43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.AOG.0000163253.27610.b9","article-title":"Endometrial effects of Bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women","volume":"105","author":"Ronkin","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2024.176611_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of bcr-abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2024.176611_bib45","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3748\/wjg.v29.i14.2078","article-title":"Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives","volume":"29","author":"Roy","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2024.176611_bib46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2017.08.014","article-title":"Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting er\u03b1 and ppar-\u0393","volume":"461","author":"Rzemieniec","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.176611_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"Jak-stat pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.176611_bib48","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2024.176611_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00198-011-1775-y","article-title":"Individualizing osteoporosis therapy","volume":"23","author":"Silverman","year":"2012","journal-title":"Osteoporos. Int. : A J. Established Result Cooperat. Between Eur. Found. Osteoporos. Natl Osteoporos. Found. USA"},{"key":"10.1016\/j.ejphar.2024.176611_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12938\/bmfh.2022-073","article-title":"Administration of Bifidobacterium pseudolongum suppresses the increase of colonic serotonin and alleviates symptoms in dextran sodium sulfate-induced colitis in mice","volume":"42","author":"Tatsuoka","year":"2023","journal-title":"Biosci. microbiota, food and health"},{"key":"10.1016\/j.ejphar.2024.176611_bib51","article-title":"Bazedoxifene regulates Th17 immune response to ameliorate experimental autoimmune myocarditis via inhibition of Stat3 activation","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176611_bib52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/cr.2010.175","article-title":"Nf-\u03bab in the regulation of epithelial homeostasis and inflammation","volume":"21","author":"Wullaert","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2024.176611_bib53","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/14656566.2019.1615882","article-title":"Bazedoxifene for the treatment of osteoporosis","volume":"20","author":"Yavropoulou","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.176611_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175681","article-title":"Bazedoxifene attenuates intestinal injury in sepsis by suppressing the nf-\u03bab\/nlrp3 signaling pathways","volume":"947","author":"Zhang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176611_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.canlet.2015.10.002","article-title":"Anthracyclines potentiate anti-tumor immunity: a new opportunity for chemoimmunotherapy","volume":"369","author":"Zhang","year":"2015","journal-title":"Cancer Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:46:58Z","timestamp":1716230818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924002991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":55,"alternative-id":["S0014299924002991"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176611","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-\u03baB pathways","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176611"}}